Digital Longevity: From Hype to HealthTech’s Next Investment Magnet

For many, “longevity” still suggests supplements or wellness retreats. In reality, the sector is becoming one of the fastest-growing segments of digital health. The new generation of longevity solutions is built on biomarker platforms, AI-driven diagnostics, preventive health coaching, and continuous at-home monitoring. Together, they promise not just longer lives, but healthier years — and investors are taking note.

R2G Connect has responded to this demand by launching a dedicated Longevity Pitching Event, giving startups direct access to investors who are actively shaping this emerging field.

Funding Surge Confirms Market Momentum

The longevity sector attracted $8.49 billion across 331 deals in 2024, according to industry trackers. This rebound signals more than hype: it reflects growing conviction that longevity solutions are commercially viable and scalable.

The broader HealthTech market supports this trend. In H1 2025, startups in the US and Europe raised $7.9 billion, with AI-powered health platforms among the most attractive investment categories. Much of this capital is flowing into companies positioned at the intersection of data-rich platforms, remote diagnostics, and actionable health insights.

Recent deals illustrate this dynamic:

NEKO Health raised $260M in a round led by Lightspeed, General Catalyst, Lakestar, and Atomico for its full-body AI scanning clinics.
Function Health secured a Series A led by a16z Bio + Health to expand its biomarker-driven preventive health model.
Clinique La Prairie announced a €100M Longevity Fund to target near-market solutions in diagnostics, wearables, and AI-based health platforms.

Five Digital Longevity Categories to Watch

The digital longevity market is consolidating around five main categories, each with distinct use cases and leading players.

Biomarker & Aging Clocks

These solutions quantify biological age through epigenetics, proteomics, glycans, or AI models — turning aging into a measurable metric.

Tally Health, epiAge – at-home swab tests with longitudinal tracking.
GlycanAge – immune-focused biomarker insights.
Zymo Research (DNAge) – consumer application of Horvath’s methylation clock.
Deep Longevity (SenoClock®) – integrates biomarkers, blood data, and psychological models.
Gero + Scripps – AI modeling of aging trajectories and geroprotector identification.
Epiclock, Vero – emerging solutions in organ-specific proteomics and genotyping.

Preventive Health & Lifestyle Optimization

Platforms in this category use diagnostics to deliver personalized, daily interventions.

Function Health – tracks 100+ health markers in a subscription model.
Lifeforce – diagnostics and telehealth paired with supplementation.
Superpower – AI-driven preventive health coaching.
AVEA, Thorne, AG1 – supplement players embedding diagnostics into personalized plans.
AgelessRx – telemedicine for longevity therapeutics such as rapamycin or NAD+.

Early Detection & Screening

Solutions focused on catching disease processes before symptoms emerge.

NEKO Health – full-body AI scanning.
Prenuvo – MRI-based preventive imaging.
Biograph, Healthy.io – diagnostics for longitudinal tracking, including smartphone-based urine tests.
Loovi, LongevityEHR – platforms for continuous health and biomarker monitoring.
SiPhox Health – countertop and mail-in blood testing solutions.

Therapeutic Discovery & Geroprotectors

These companies do not manufacture drugs but provide the AI and data infrastructure for identifying and validating geroprotective pathways.

Insilico Medicine – AI-driven pipeline for age-related therapeutics.
AgeXtend – computational discovery of geroprotectors.
Longevity.AI – mapping and database for longevity biotech pipelines.
BioAge Data – omics-based analytics of aging signatures.
Rejuve.AI – decentralized AI models for predicting interventions.
Aging Analytics Agency – global intelligence platform on longevity R&D.

At-Home Testing & Real-Time Vitals Tracking

This segment connects consumers and clinicians to continuous streams of health data.

Eko Health – AI-powered stethoscopes for early detection.
CardiacSense, Empatica – wearables tracking cardiovascular and neurological health.
Hexoskin – biometric garments capturing ECG and respiratory function.
Tellihealth – connected monitoring for remote patient care.
CONNEQT Health – vascular monitoring solutions enabling preventive cardiovascular management.

Strategic Signals for Investors

Longevity is investable now: The sector’s $8.5B raise in 2024 puts it on par with other fast-growing health verticals.
Data is the differentiator: The value of continuous, longitudinal health data is creating defensibility for startups like NEKO and Function Health.
Consumer–clinic hybrid models will dominate: The winning companies blend digital-first convenience with clinical-grade credibility, creating models attractive to both patients and payers.

R2G Connect Longevity Pitching Event

The next step for this market is visibility and scaling. To address this, R2G Connect is hosting the Longevity Pitching Event, bringing together:

Startups from biomarkers, preventive health, diagnostics, geroprotectors, and at-home monitoring.
Investors actively scouting the next wave of digital longevity solutions.

This is a unique opportunity for founders to showcase their innovation directly to capital allocators driving the longevity market.

Applications are open now: R2G Connect Longevity Pitching Event

References: